BioScene Pharma is an innovative pharmaceutical enterprise that drives the development of the entire pharmaceutical industry chain with drug research and development. Taking advantage of the new medical policies, BioScene is based on the system of drug marketing authorization holder, and mainly engaged in the research and development of 505(b)(2) new drugs and high-end characteristic generic drugs. The main business of BioScene is to develop self-held new drug products, build core technology platforms, and provide new drug product research and development services for domestic and foreign customers, so as to build the company's core competitiveness in an all-round way.

The core team of BioScene is composed of several pharmaceutical PhDs from domestic and foreign institutions and pharmaceutical companies with more than 20 years of industry experience. BioScene has a complete junior and senior technical management teams, the top project establishment and R&D experience and ability in China. BioScene has established good cooperative relationship with the international first-class new drug research and development institutions, good CMO cooperation relationship with domestic first-class chemical API and pharmaceutical preparation manufacturing enterprises, and an expert committee with a number of industry experts for project evaluation and R&D support.

BioScene will lead the technological and management innovation of the enterprise with an international vision, build the core competitiveness of the enterprise with an open and cooperative attitude, and forge the core value of the enterprise with the realistic and pragmatic style. Guided by clinical and market demands, the product pipeline of BioScene is constructed on the basis of the MAH policies and a complete and powerful R&D and quality management team. With the aim of developing 505(b)(2) new drugs and characteristic generic drugs, we will promote the core value of BioScene by developing good new drugs that truly benefit global patients, and create the most beautiful scenery in the pharmaceutical industry.